New York City Children's Center (NYCCC) - Queens Campus

Details

Name :

New York City Children's Center (NYCCC) - Queens Campus

Address  :

74-03 Commonwealth Boulevard

Town  :

Bellerose

State  :

New York

Country  :

USA

Post Code:

11426

Phone  :

718 264 4500

Fax  :

718 264 4810

Web URL  :

New York City Childrens Center NYCCC  Queens Campus
Specialization
  • Physiology
  • Psychiatrist
Facilities
  • Recreation Therapy


Description

NYCCC is a leader in providing quality behavioral health services that are

individualized
evidencedbased
outcome driven
resiliency building
All services are of the highest quality culturally relevant and incorporate families as partners in the treatment process

We continuously strive to improve the quality and efficacy of services through an ongoing process of assessment and evaluation

Mission

Provide comprehensive individualized mental health treatment to children and adolescents with mental illness in a therapeutic environment

Values

NYCCC pursues excellence by engaging in activities that promote quality innovation and efficiency

We believe every person has individual worth and deserves the right to be treated with dignity and kindness

Our services are family focused and youthcentered

We provide services in a therapeutic strength building environment free from injury danger or emotional harm

We are tolerant and respectful of differences in

ethnicity
culturecultural background
spiritual beliefs
sexual orientation
ideas and opinions
NYCCC staff members maintain high ideals of ethical conduct and behavior
Recycled Kidney Successfully Implanted into 2nd Recipient after First Failed Transplant

Surgeons have successfully transplanted a kidney that had already been transplanted in one patient but started to fail into a second patient doctors reported on Wednesday In a report published in the the New England Journal of Medicine doctors documented the groundbreaking procedures of a kidney that had been transplanted twice in two weeks A... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More